These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25167997)

  • 1. Economic effects of treatment of chronic kidney disease with low-protein diet.
    Mennini FS; Russo S; Marcellusi A; Quintaliani G; Fouque D
    J Ren Nutr; 2014 Sep; 24(5):313-21. PubMed ID: 25167997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental cost effectiveness of pharmacist-managed erythropoiesis-stimulating agent clinics for non-dialysis-dependent chronic kidney disease patients.
    Aspinall SL; Smith KJ; Good CB; Zhao X; Stone RA; Tonnu-Mihara IQ; Cunningham FE
    Appl Health Econ Health Policy; 2013 Dec; 11(6):653-60. PubMed ID: 24092553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of sevelamer in patients with end-stage renal disease.
    Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
    Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
    Pradelli L; Iannazzo S; Zaniolo O
    Am J Cardiovasc Drugs; 2009; 9(6):383-92. PubMed ID: 19929036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which low-protein diet for which CKD patient? An observational, personalized approach.
    Piccoli GB; Deagostini MC; Vigotti FN; Ferraresi M; Moro I; Consiglio V; Scognamiglio S; Mongilardi E; Clari R; Aroasio E; Versino E; Porpiglia F
    Nutrition; 2014 Sep; 30(9):992-9. PubMed ID: 25102817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of everolimus versus sorafenib for the treatment of metastatic renal cell carcinoma after failure of first-line sunitinib.
    Casciano R; Chulikavit M; Di Lorenzo G; Liu Z; Baladi JF; Wang X; Robertson J; Garrison L
    Value Health; 2011; 14(6):846-51. PubMed ID: 21914504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients.
    Scalone L; Borghetti F; Brunori G; Viola BF; Brancati B; Sottini L; Mantovani LG; Cancarini G
    Nephrol Dial Transplant; 2010 Mar; 25(3):907-13. PubMed ID: 20008828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive effects of protein restriction in patients with chronic kidney disease.
    Eyre S; Attman PO; Haraldsson B
    J Ren Nutr; 2008 May; 18(3):269-80. PubMed ID: 18410883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard.
    Lee CP; Chertow GM; Zenios SA
    Value Health; 2009; 12(1):80-7. PubMed ID: 19911442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis.
    Naci H; de Lissovoy G; Hollenbeak C; Custer B; Hofmann A; McClellan W; Gitlin M
    J Med Econ; 2012; 15(2):293-304. PubMed ID: 22115328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
    Komaba H; Moriwaki K; Goto S; Yamada S; Taniguchi M; Kakuta T; Kamae I; Fukagawa M
    Am J Kidney Dis; 2012 Aug; 60(2):262-71. PubMed ID: 22445709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Denmark kidney transplantation is more cost-effective than dialysis.
    Jensen CE; Sørensen P; Petersen KD
    Dan Med J; 2014 Mar; 61(3):A4796. PubMed ID: 24814915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States.
    Sanon M; Taylor DC; Parthan A; Coombs J; Paolantonio M; Sasane M
    J Med Econ; 2013; 16(1):150-9. PubMed ID: 22762291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
    Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can renal nutrition education improve adherence to a low-protein diet in patients with stages 3 to 5 chronic kidney disease?
    Paes-Barreto JG; Silva MI; Qureshi AR; Bregman R; Cervante VF; Carrero JJ; Avesani CM
    J Ren Nutr; 2013 May; 23(3):164-71. PubMed ID: 23194841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
    Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC
    Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.
    Hoerger TJ; Wittenborn JS; Segel JE; Burrows NR; Imai K; Eggers P; Pavkov ME; Jordan R; Hailpern SM; Schoolwerth AC; Williams DE;
    Am J Kidney Dis; 2010 Mar; 55(3):463-73. PubMed ID: 20116910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
    Hogendoorn W; Hunink MG; Schlösser FJ; Moll FL; Muhs BE; Sumpio BE
    J Vasc Surg; 2014 Sep; 60(3):715-25.e2. PubMed ID: 24721175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
    Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
    Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.